Table 3.
Comparison of prognostic factors between sustained responsive group and nonsustained responsive group.
| Clinical and laboratoristic prognostic factors | The SR group | The non-SR group | P |
|---|---|---|---|
| Patients' number | 28 | 25 | |
| Males/females | 12/16 | 6/19 | 0.154 |
| Mean age, years | 32 (14–58) | 36 (14–65) | 0.302 |
| Mean duration, years | 3.07 (2–6) | 2.88 (2–5) | 0.504 |
| Mean baseline Plt, ×109/L | 22.96 (11–31) | 21.96 (11–35) | 0.581 |
| Mean MEG count in bone marrow slide | 107 (34–213) | 91 (34–147) | 0.088 |
| Mean numbers of previous treatments | 3 (2–4) | 3 (2–5) | 0.584 |
The SR/non-SR group included patients with SR/non-SR in both groups; MEG: megakaryocyte; Plt: platelet.